Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Exicure Announces Positive Phase 1 Results for Lead Immuno-Oncology Asset

americanpharmaceuticalreviewSeptember 21, 2018

Tag: Exicure , Lead , Asset

PharmaSources Customer Service